Edesa Biotech, Inc. Gains 81.38%

Edesa Biotech, Inc. (EDSA:NASDAQ) shot up at $9.45, a gain of 81.4%. The stock got featured on our News Catalysts scanner on Thu 30 Jul 20 at 08:08 AM in the 'BIOTECH' category. From Wed 15 Jul 20, the stock recorded 50.00% Up Days and 45.45% Green Days

The stock spiked on Mon 15 Jun 20 at $10 with a volume of 55M+, and its share price has been moving sideways in recent weeks.

About Edesa Biotech, Inc. (EDSA:NASDAQ)

Stellar Biotechnologies Inc is a biotechnology company. The company is engaged in the aquaculture, research, and development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein with an extensive history of safe and effective use in immunological applications. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a variety of diseases. It derives its revenues mostly from Europe. Stellar primarily market and distribute products directly to biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers.